In-stent restenosis (ISR) is a difficult complication to treat, occurring in 15–35% of stents deployed for de novo lesions in native coronary arteries.1,2 The restenosis rate following therapy for ISR is as high as 54%.3 Thus far, there is...
In-stent restenosis (ISR) is a difficult complication to treat, occurring in 15–35% of stents deployed for de novo lesions in native coronary arteries.1,2 The restenosis rate following therapy for ISR is as high as 54%.3 Thus far, there is...
In-stent restenosis (ISR) is a...